Victor Daddio, MD
Vascular Surgery · Fredericksburg, VANPI 1427002948
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 34.6% of the total. Reporting peaked in 2019 at $4,554 and has fallen 85.0% since, to $685 in 2025.
Across 112 payments — averaging $91.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Spineart USA Inc$3K
- Silk Road Medical, Inc.$3K
- Boston Scientific$437
- Cvrx, Inc.$146
- Lemaitre Vascular, Inc.$139
- plus $337 from 5 others
What the payments were for
- Travel & lodging$4,74946%
- Food & beverage$5,46754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 62 | $3,530 |
| Spineart USA Inc | 2 | $2,980 |
| Silk Road Medical, Inc. | 23 | $2,646 |
| Boston Scientific | 11 | $437 |
| Cvrx, Inc. | 2 | $146 |
| Lemaitre Vascular, Inc. | 3 | $139 |
| Endologix LLC | 4 | $137 |
| Cook Medical LLC | 2 | $118 |
| Angiodynamics, Inc. | 1 | $39 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,494
- ENROUTE Transcarotid Stent$2,229
- GORE EXCLUDER AAA Endoprosthesis$689
- EXCLUDER AAA Endoprosthesis$676
- ENROUTE .014 Guidewire$562
- ENHANCE Transcarotid Peripheral Access Kit$562
- EXCLUDER Iliac Branch Endoprosthesis$527
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$434
- GORE TAG Thoracic Branch Endoprosthesis$158
- Barostim Neo System$125
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$115
- Conformable TAG Thoracic Endoprosthesis$105
- Zenith$102
How this compares
$10,215 in reported general payments places this provider in the 60th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $28,060 |
| ClopidogrelClopidogrel Bisulfate | 84 | $1,419 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Fredericksburg
- Frank KoenigFredericksburg$16K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
- Joshua AdamsRoanoke$138K
- Richard NevilleFalls Church$114K
- Anthony ComerotaFalls Church$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.